Le Lézard
Classified in: Business
Subject: STR

IIROC Trading Resumption - MSCL


VANCOUVER, BC, April 19, 2023 /CNW/ - Trading resumes in:

Company: Satellos Bioscience Inc. 

TSX-Venture Symbol: MSCL 

All Issues: Yes

Resumption (ET): 11:00 AM

IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

SOURCE Investment Industry Regulatory Organization of Canada (IIROC) - Halts/Resumptions


These press releases may also interest you

at 01:00
Brinc Acquires Callmi - MENA's #1 Mentorship Platform
Brinc, a global leader in corporate innovation and venture acceleration has acquired Callmi, a MENA-centric mentorship platform that offers 1:1 video consultations with top-tier expertsCallmi will scale offerings to users and also be further...

at 00:23
Flash News: OKX to List ARB/USDC Spot Trading Pair
OKX, a leading crypto exchange by trading volume and a leading Web3 technology company, has issued updates for May 17, 2024. OKX to...

16 mai 2024
Flash News: OKX Launches Cryptopedia Season 18, Offering Users Up to USD200,000 in BDXN Tokens for Completing Bondex-Related Quests
OKX, a leading Web3 technology company, has issued updates for May 16, 2024. OKX Launches Cryptopedia Season 18, Offering Users Up to...

16 mai 2024
GC congratulates NatureWorks and Krungthai Bank on closing a significant financing deal for NatureWorks' Ingeo PLA Manufacturing Expansion worth 12.6 billion baht, Supporting Thailand's Ambitious Bio-Circular-Green (BCG) Strategy
Mr. Narongsak Jivakanun (Second from left), CEO of PTT Global Chemical Public Company Limited (GC) presided over the signing ceremony and extended his congratulations to Krungthai Bank and NatureWorks - a joint venture of GC and a leading...

16 mai 2024
Proteologix, Inc. to be Acquired by Johnson & Johnson
Proteologix, Inc., a privately-held biotechnology company focused on bispecific antibodies for immune-mediated diseases, today announced that it has entered into a definitive agreement to be acquired by Johnson & Johnson for $850 million in cash,...

16 mai 2024
Velan Inc. Reports Its Fiscal 2024 Fourth Quarter and Year-End Results
Velan Inc. ("Velan" or the "Company"), a world-leading manufacturer of industrial valves, announced today its financial results for its fourth quarter and fiscal year ended February 29, 2024. All amounts are expressed in U.S. dollars unless...

More news about Business...


News published on and distributed by: